Literature DB >> 20175183

Self-rated health status in spinocerebellar ataxia--results from a European multicenter study.

Tanja Schmitz-Hübsch1, Mathieu Coudert, Paola Giunti, Christoph Globas, Laszlo Baliko, Roberto Fancellu, Caterina Mariotti, Alessandro Filla, Maryla Rakowicz, Perrine Charles, Pascale Ribai, Sandra Szymanski, Jon Infante, Bart P C van de Warrenburg, Alexandra Dürr, Dagmar Timmann, Sylvia Boesch, Rafal Rola, Chantal Depondt, Ludger Schöls, Elszbieta Zdzienicka, Jun-Suk Kang, Susanne Ratzka, Berry Kremer, Jörg B Schulz, Thomas Klopstock, Bela Melegh, Sophie Tezenas du Montcel, Thomas Klockgether.   

Abstract

Patient-based measures of subjective health status are increasingly used as outcome measures in interventional trials. We aimed to determine the variability and predictors of subjective health ratings in a possible target group for future interventions: the spinocerebellar ataxias (SCAs). A consecutive sample of 526 patients with otherwise unexplained progressive ataxia and genetic diagnoses of SCA1 (117), SCA2 (163), SCA3 (139), and SCA6 (107) were enrolled at 18 European referral centers. Subjective health status was assessed with a generic measure of health related quality of life, the EQ-5D (Euroqol) questionnaire. In addition, we performed a neurological examination and a screening questionnaire for affective disorders (patient health questionnaire). Patient-reported health status was compromised in patients of all genotypes (EQ-5D visual analogue scale (EQ-VAS) mean 61.45 +/- 20.8). Specifically, problems were reported in the dimensions of mobility (86.9% of patients), usual activities (68%), pain/discomfort (49.4%), depression/anxiety (46.4%), and self care (38.2%). Multivariate analysis revealed three independent predictors of subjective health status: ataxia severity, extent of noncerebellar involvement, and the presence of depressive syndrome. This model explained 30.5% of EQ-VAS variance in the whole sample and might be extrapolated to other SCA genotypes. (c) 2010 Movement Disorder Society.

Entities:  

Mesh:

Year:  2010        PMID: 20175183     DOI: 10.1002/mds.22740

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  26 in total

1.  Long-term evolution of patient-reported outcome measures in spinocerebellar ataxias.

Authors:  Heike Jacobi; Sophie Tezenas du Montcel; Peter Bauer; Paola Giunti; Arron Cook; Robyn Labrum; Michael H Parkinson; Alexandra Durr; Alexis Brice; Perrine Charles; Cecilia Marelli; Caterina Mariotti; Lorenzo Nanetti; Lidia Sarro; Maria Rakowicz; Anna Sulek; Anna Sobanska; Tanja Schmitz-Hübsch; Ludger Schöls; Holger Hengel; Laszlo Baliko; Bela Melegh; Alessandro Filla; Antonella Antenora; Jon Infante; José Berciano; Bart P van de Warrenburg; Dagmar Timmann; Sandra Szymanski; Sylvia Boesch; Wolfgang Nachbauer; Jun-Suk Kang; Massimo Pandolfo; Jörg B Schulz; Audrey Tanguy Melac; Alhassane Diallo; Thomas Klockgether
Journal:  J Neurol       Date:  2018-06-29       Impact factor: 4.849

2.  Longitudinal study of cognitive and psychiatric functions in spinocerebellar ataxia types 1 and 2.

Authors:  Roberto Fancellu; Dominga Paridi; Chiara Tomasello; Marta Panzeri; Anna Castaldo; Silvia Genitrini; Paola Soliveri; Floriano Girotti
Journal:  J Neurol       Date:  2013-12       Impact factor: 4.849

3.  Depressive mood is associated with ataxic and non-ataxic neurological dysfunction in SCA3 patients.

Authors:  Jonas Alex Morales Saute; Andrew Chaves Feitosa da Silva; Karina Carvalho Donis; Leonardo Vedolin; Maria Luiza Saraiva-Pereira; Laura Bannach Jardim
Journal:  Cerebellum       Date:  2010-12       Impact factor: 3.847

4.  Nonmotor Symptoms in Patients with Spinocerebellar Ataxia Type 10.

Authors:  Adriana Moro; Renato P Munhoz; Mariana Moscovich; Walter O Arruda; Salmo Raskin; Laura Silveira-Moriyama; Tetsuo Ashizawa; Hélio A G Teive
Journal:  Cerebellum       Date:  2017-12       Impact factor: 3.847

5.  Car8 dorsal root ganglion expression and genetic regulation of analgesic responses are associated with a cis-eQTL in mice.

Authors:  Roy C Levitt; Gerald Y Zhuang; Yuan Kang; Diana M Erasso; Udita Upadhyay; Mehtap Ozdemir; Eugene S Fu; Konstantinos D Sarantopoulos; Shad B Smith; William Maixner; Luda Diatchenko; Eden R Martin; Tim Wiltshire
Journal:  Mamm Genome       Date:  2017-05-25       Impact factor: 2.957

6.  Fatigue in spinocerebellar ataxia: patient self-assessment of an early and disabling symptom.

Authors:  Esther Brusse; Marjolein G J Brusse-Keizer; Hugo J Duivenvoorden; John C van Swieten
Journal:  Neurology       Date:  2011-03-15       Impact factor: 9.910

7.  Inventory of Non-Ataxia Signs (INAS): validation of a new clinical assessment instrument.

Authors:  H Jacobi; M Rakowicz; R Rola; R Fancellu; C Mariotti; P Charles; A Dürr; M Küper; D Timmann; C Linnemann; L Schöls; O Kaut; C Schaub; A Filla; L Baliko; B Melegh; J-S Kang; P Giunti; B P C van de Warrenburg; R Fimmers; T Klockgether
Journal:  Cerebellum       Date:  2013-06       Impact factor: 3.847

Review 8.  The effectiveness of allied health care in patients with ataxia: a systematic review.

Authors:  Ella M R Fonteyn; Samyra H J Keus; Carla C P Verstappen; Ludger Schöls; Imelda J M de Groot; Bart P C van de Warrenburg
Journal:  J Neurol       Date:  2013-04-16       Impact factor: 4.849

9.  Physiotherapy in degenerative cerebellar ataxias: utilisation, patient satisfaction, and professional expertise.

Authors:  Ella M R Fonteyn; Samyra H J Keus; Carla C P Verstappen; Bart P C van de Warrenburg
Journal:  Cerebellum       Date:  2013-12       Impact factor: 3.847

10.  Quality of Life since Pre-Ataxic Phases of Spinocerebellar Ataxia Type 3/Machado-Joseph Disease.

Authors:  Gabriela Bolzan; Vanessa Bielefeldt Leotti; Camila Maria de Oliveira; Gabriela Ecco; Amanda Henz Cappelli; Anastacia Guimarães Rocha; Nathalia Kersting; Mariana Rieck; Lucas Schenatto de Sena; Ana Carolina Martins; Maria-Luiza Saraiva-Pereira; Laura Bannach Jardim
Journal:  Cerebellum       Date:  2021-07-06       Impact factor: 3.847

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.